Safety and efficacy of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world clinical practice: Results of 3‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT)

AIMS/INTRODUCTION: The present study analysis was carried out to evaluate the safety and efficacy of tofogliflozin, a sodium–glucose cotransporter 2 inhibitor, in Japanese patients with type 2 diabetes mellitus in real‐world clinical practice. MATERIALS AND METHODS: This was a 3‐year non‐interventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Utsunomiya, Kazunori, Senda, Masayuki, Kakiuchi, Seigo, Kameda, Hiroyuki, Tamura, Masahiro, Kurihara, Yuji, Gunji, Ryoji, Fujii, Shoko, Fujiwara, Hisataka, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717810/
https://www.ncbi.nlm.nih.gov/pubmed/30702214
http://dx.doi.org/10.1111/jdi.13017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717810/
https://www.ncbi.nlm.nih.gov/pubmed/30702214
http://dx.doi.org/10.1111/jdi.13017

Ejemplares similares